Eddy retweeted
You can see just how fragile this market is when a short report from a small shop like Hunterbrook comes out and a $1T company like $AMD is suddenly down more than 10%.
And the report itself acknowledges that “no export-control violation has been established.”
Eddy retweeted
$AAOI
$AAOI has only 16.88 million uncommitted common shares left under its 120.00 million corporate charter cap, creating a hard legal ceiling at $32.58 per share for completing its new $550 million ATM.
Per the November 17 Form 424B5 and Q3 Form 10-Q, Applied Optoelectronics already has 90.77 million common shares outstanding as of November 16, up 83.8% from 49.39 million at year-end 2024. Another 12.35 million shares are contractually spoken for: 7.95 million reserved for the Amazon warrant at a $23.70 strike, 2.88 million underlying the 2.75% convertible notes due 2030 at a $43.31 conversion price, and 1.52 million in unvested RSUs and PSUs.
That leaves 103.12 million shares issued or reserved before a single share of ATM #4 hits the tape, even prior to counting ungranted reserves in the June 2026 incentive plan. Selling $550 million at the $45.16 filing reference price absorbs 12.18 million shares, or 72.1% of AOI's remaining legal headroom.
If persistent ATM selling pushes the average execution price below $32.58, AOI physically exhausts its 120.00 million authorized common share limit and must seek a shareholder charter amendment to print more common stock.
$AAOI
Shares of $AAOI slipped to $43.25 after hours following its $550 million equity ATM filing, stinging investors who trusted management's explicit assurance from twelve days earlier.
On the November 5 Q3 call at $46.89, CFO Stefan Murry told analysts Applied Optoelectronics was leaning more on debt than equity, while CEO Thompson Lin highlighted a new $200 million bank revolver and floated $400 million to $500 million in U.S. loans alongside internal profits. On that same call, the CFO projected higher 2027 CapEx moments before the CEO contradicted him live in Q&A, and twelve days later AOI launched up to $550 million in stock sales against $928.8 million in non-cancellable purchase commitments.
Management's financing guidance carried a twelve-day shelf life once real factory bills came due.
KOREAN MEDIA: MAJOR CHINESE CLOUD SERVICE PROVIDERS (CSPS), INCLUDING ALIBABA, TENCENT, AND BYTEDANCE, HAVE REQUESTED LONG-TERM SUPPLY AGREEMENTS (LTAS) FOR SERVER MEMORY FROM SAMSUNG ELECTRONICS AND SK HYNIX.
BEYOND THE TYPICAL THREE-TO-FIVE-YEAR TERM, SOME CUSTOMERS ARE SEEKING ULTRA-LONG-TERM CONTRACTS SECURING MEMORY SUPPLIES FOR 10 YEARS THROUGH 2035. THE REQUESTED LTAS COVER DDR5 AND LPDDR5.
LEE HYOUNG-IL, SOUTH KOREA’S DEPUTY PRIME MINISTER AND MINISTER OF FINANCE AND ECONOMY: WE ARE PREPARING TO DEPLOY MARKET STABILIZATION MEASURES IF STOCK MARKET VOLATILITY INCREASES.
WE WILL DECIDE WHETHER TO IMPLEMENT SPECIFIC MEASURES, SUCH AS ACTIVATING THE STOCK MARKET STABILIZATION FUND OR TEMPORARILY BANNING SHORT SELLING, BASED ON MARKET CONDITIONS.
Eddy retweeted
$DELL CEO Michael Dell says memory shortage is going to “get worse” next year with ~$95B in AI server backlog and DRAM supply still limiting deliveries.
With new memory fabs unlikely to provide meaningful relief until 2029 or 2030, the 2027 oversupply fears weighing on $MU and $SKHY look really disconnected from what customers are actually seeing.
Eddy retweeted
$CRWV isn’t paying 15% interest. Only 4% of their debt costs that.
I went through the Q2 10-Q line by line. Out of ~$35B in debt, exactly one loan sits at 15%. It’s $1.3B, due March 2028, and already being paid down.
The 15% chart going around is the market yield on their 2032 bond. A higher yield doesn’t change what CoreWeave pays. It works like a mortgage. If you locked in at 3% and rates go to 7%, you’re still paying 3%. CoreWeave locked that bond at 9.625% and still pays 9.625%.
What they actually pay
> $6.6B of convertibles at ~2%
> ~$10B of bonds at 9-10%
> Most secured loans around 9%
> ~8.4% blended across everything
They have roughly $20B of 2026 capex left to fund, and 2027 will need more. Their main funding tool has been loans backed by customer contracts. The investment grade one backed by Meta priced around 5.9% in March. If they keep borrowing that way, I think the math holds.
Zooming out, the AI trade still looks intact to me. $ASML reported record Q3 profit this morning and said lithography demand will outrun their supply in 2027 and 2028, even after adding ~30% capacity each year. Customers are already asking about 2029 and 2030 slots.
Demand is still outpacing supply everywhere I look. $CRWV $ASML
Watching people freak out over CXMT's 4F² and claim that CXMT has caught up with Western memory technology is honestly laughable.
CXMT has hit the limits of DUV scaling. What it is trying to do is move from 6F² to 4F² at the relatively relaxed 13 to 14nm node so it can extend the life of DUV. It is not jumping straight to 4F² to leapfrog Western memory makers that use EUV. People have the cause and effect backwards.
Samsung and SK hynix are also not holding off on 4F² because they are stupid. If they wanted to mass produce 4F² right now, they actually could. The only reason they don't is that the yields aren't there.
I really can't make sense of this selloff sparked by CXMT. 🤡
Eddy retweeted
People really need to stop thinking about 5% yields over 10 years or 30 years.
Even the inflation of my $SUBWAY sandwich has gone up like 12% a year.
Today it was like $20 after tax, when it used to be like $5… 12 years ago.
The best way to keep up with inflation of the things that matter, like Sandwiches, is equities like $SPY.
$BETR down ~7%
When you hunt 100-baggers you have some big hits and some big misses.
BETR has been my biggest miss — I own none of it today. This isn't a stock call, it's a governance call: the company is better off with Vishal Garg than with the people who ousted him.
If you hold BETR, consider voting GREEN — he's at 46% and needs 50.01%.
1
206
Eddy retweeted
New report from Bloomberg on $IQE:
“indium phosphide substrates is emerging as a key risk for the semiconductor industry.”
I wonder who could have guessed this last year with $AXTI?
Oh look… a new report by Reuters shows China’s control over InP threatens the AI DC buildout.
Who could have guessed $AXTI would have been a major point of failure?
Eddy retweeted
I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year.
Burnt a lot of credits, and the results are in:
OpenAI: - $KYTX (autoimmune CAR-T results)
- $PRQR (human RNA-editing datasets)
- $VSTM (KRAS cancer-drug)
- $CNTB (asthma and COPD)
- $RANI (oral biologics)
- $IVA (MASH)
- $SILC (networking + inference hardware)
- $AMPX (batteries)
- $EOSE (batteries)
- $ZVRA (rare-disease drug growth)
Anthropic: - $INO (respiratory papillomatosis)
- $CAPR (PDUFA for deramiocel)
- $GOSS (seralutinib)
- $SLS (Phase 3 binary)
- $IREN (familiar face)
- $WULF (familiar face)
- $OKLO (nuclear)
- $SMR (nuclear)
- $RGTI (quantum)
- $QBTS (quantum)
*Disclosure don't own any of these aside from 1 share in IREN, not a recommendation, just TLDR of LLM output for educational purposes.
So very interesting results:
Our beloved AGI Astra prefers really obscure biotech I've never heard about. And a few familiar names like $EOSE and $AMPX.
And Fable... yeah idk, feels like it learned a little too much from /r/wallstreetbets and X but maybe it's right, who knows.
Anyway no judgement, I'll save this and revisit it in a few months. If one of them actually delivers... I'll be impressed.



































